<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" nameag="viewport"/>
<title>Asthma</title>
<script src="https://cdn.tailwindcss.com"></script>
<script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
<script src="https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js"></script>
<style>
        /* Custom styles for enhanced aesthetics and responsiveness */
        .option-btn {
            transition: all 0.3s ease;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
        }
        .option-btn:hover, .option-btn:active {
            transform: scale(1.02);
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
        }
        .option-btn.selected {
            background-color: #3b82f6;
            color: white;
        }
        .marked {
            background-color: #fef08a;
        }
        .progress-bar {
            transition: width 0.5s ease-in-out;
            background: linear-gradient(to right, #3b82f6, #22c55e);
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
            animation: pulse 2s infinite;
        }
        @keyframes pulse {
            0% { opacity: 1; }
            50% { opacity: 0.8; }
            100% { opacity: 1; }
        }
        .question-nav-btn, .result-nav-btn-grid {
            width: 40px;
            height: 40px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 8px;
            font-size: 16px;
            touch-action: manipulation;
            transition: all 0.2s ease;
        }
        .question-nav-btn:hover, .question-nav-btn:active, .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
            transform: scale(1.05);
        }
        .answered {
            background-color: #22c55e;
            color: white;
        }
        .unanswered {
            background-color: #e5e7eb;
        }
        .marked-nav {
            border: 2px solid #fef08a;
        }
        .video-container, .audio-container {
            display: none;
            position: relative;
        }
        .video-container.active, .audio-container.active {
            display: block;
            animation: fadeIn 0.5s ease-in;
        }
        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }
        .section-transition {
            transition: opacity 0.3s ease;
        }
        .section-transition.hidden {
            opacity: 0;
            pointer-events: none;
        }
        .result-nav {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-top: 1rem;
        }
        .result-nav-btn {
            background-color: #4b5563;
            color: white;
            padding: 0.5rem 1rem;
            border-radius: 8px;
            transition: all 0.2s ease;
        }
        .result-nav-btn:hover, .result-nav-btn:active {
            background-color: #374151;
            transform: scale(1.05);
        }
        .result-nav-btn:disabled {
            background-color: #d1d5db;
            cursor: not-allowed;
        }
        .error-message {
            color: #dc2626;
            font-weight: bold;
            margin-top: 1rem;
        }
        /* Mobile-specific adjustments */
        @media (max-width: 640px) {
            .question-nav-btn, .result-nav-btn-grid {
                width: 38px;
                height: 38px;
                font-size: 14px;
            }
            .nav-panel, .results-nav-panel {
                width: 100%;
                max-width: 100%;
                overscroll-behavior: contain;
            }
            .option-btn {
                padding: 12px;
                font-size: 14px;
            }
            .header-text {
                font-size: 1.5rem;
            }
            .subheader-text {
                font-size: 0.875rem;
            }
            .button-group, .result-nav {
                flex-direction: column;
                gap: 0.5rem;
            }
            .result-nav-btn {
                width: 100%;
                text-align: center;
            }
        }
        /* Dark mode styles */
        .dark .bg-gray-100 {
            background-color: #1f2937;
        }
        .dark .bg-white {
            background-color: #374151;
        }
        .dark .text-gray-700 {
            color: #d1d5db;
        }
        .dark .text-gray-800 {
            color: #e5e7eb;
        }
        .dark .bg-gray-200 {
            background-color: #4b5563;
        }
        .dark .border {
            border-color: #4b5563;
        }
        .dark .bg-blue-500 {
            background-color: #2563eb;
        }
        .dark .hover\:bg-blue-600:hover {
            background-color: #1d4ed8;
        }
        .dark .bg-yellow-300 {
            background-color: #b45309;
            color: white;
        }
        .dark .hover\:bg-yellow-400:hover {
            background-color: #92400e;
        }
        .dark .bg-green-500 {
            background-color: #15803d;
        }
        .dark .hover\:bg-green-600:hover {
            background-color: #166534;
        }
        .dark .bg-gray-500 {
            background-color: #4b5563;
        }
        .dark .hover\:bg-gray-600:hover {
            background-color: #374151;
        }
        .dark .result-nav-btn, .dark .result-nav-btn-grid {
            background-color: #2563eb;
        }
        .dark .result-nav-btn:hover, .dark .result-nav-btn:active, .dark .result-nav-btn-grid:hover, .dark .result-nav-btn-grid:active {
            background-color: #1d4ed8;
        }
        .dark .result-nav-btn:disabled, .dark .result-nav-btn-grid:disabled {
            background-color: #4b5563;
        }
        .video-placeholder {
            width: 400px;
            height: 300px;
            background-color: #f0f0f0;
            display: flex;
            align-items: center;
            justify-content: center;
            cursor: pointer;
            margin-top: 10px;
            border-radius: 8px;
            border: 1px solid #ccc;
        }
        .play-icon {
            font-size: 40px;
            color: #007bff;
        }
        .video-loading {
            position: absolute;
            top: 50%;
            left: 50%;
            transform: translate(-50%, -50%);
            border: 4px solid #f3f3f3;
            border-top: 4px solid #3b82f6;
            border-radius: 50%;
            width: 40px;
            height: 40px;
            animation: spin 1s linear infinite;
        }
        @keyframes spin {
            0% { transform: translate(-50%, -50%) rotate(0deg); }
            100% { transform: translate(-50%, -50%) rotate(360deg); }
        }
    </style>

<script>
    // --- GEMINI AUTO-CAPTURE LISTENER ---
    // This function runs immediately after the quiz determines an answer is INCORRECT.
    function captureMistake(questionIndex, questionsData) {
        try {
            const item = questionsData[questionIndex];
            // Use the question text as a unique, stable identifier
            const uniqueId = 'srs_quiz_' + btoa(item.text.substring(0, 50)).replace(/=/g, ''); 

            // 1. Clean and simplify the explanation for storage
            let explanationText = item.explanation || item.correct_answer || "No explanation provided.";
            
            // Strip complex HTML (images, lists) and boilerplate text
            explanationText = explanationText.replace(/<img[^>]*>/g, "[IMAGE]").trim(); // Replace images with placeholder
            explanationText = explanationText.replace(/<p><strong>Ans\. [A-Z]\).*/i, "").trim(); // Remove the repeated Answer line
            explanationText = explanationText.replace(/<p><strong>Educational Objective:<\/strong>.*?<\/p>/gs, "").trim(); // Remove EO block
            explanationText = explanationText.replace(/@dams_new_robot/g, "");
            explanationText = explanationText.replace(/<\/?[^>]+(>|$)/g, " ").trim(); // Final strip of remaining tags

            // 2. Prepare card data
            const cardData = {
                text: item.text,
                answer: item.correct_answer,
                explanation: explanationText.substring(0, 500), // Keep explanations short
                nextReview: 0, // Due immediately
                reviews: 0,
                source: document.title.split('-')[0].trim() || 'Quiz'
            };

            // 3. Save to Local Storage (SRS Bank)
            localStorage.setItem(uniqueId, JSON.stringify(cardData));
            
            console.log(`ðŸ§  Captured Mistake #${questionIndex + 1} from ${document.title}`);

        } catch (e) {
            console.error("SRS Capture Failed:", e);
        }
    }
    // --- END GEMINI AUTO-CAPTURE LISTENER ---
</script>

</head>
<body class="bg-gray-100 font-sans transition-colors duration-300 min-h-screen overflow-y-auto">
<!-- Header Section -->
<header class="bg-blue-600 text-white p-4 shadow-lg">
<div class="container mx-auto">
<h1 class="text-2xl md:text-3xl font-bold header-text">Asthma</h1>
<p class="mt-2 text-sm md:text-base subheader-text">
                16 Questions | 16 Total Marks | 26 min Duration | ~97.5 sec/question
            </p>
<button class="mt-2 bg-gray-200 text-gray-800 px-3 py-1 rounded-lg hover:bg-gray-300 transition dark:bg-gray-600 dark:text-white" id="theme-toggle">
                Toggle Dark Mode
            </button>
</div>
</header>
<!-- Instructions Section -->
<section class="container mx-auto p-4 md:p-6 section-transition" id="instructions">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-xl font-semibold mb-4">Instructions</h2>
<ul class="list-disc list-inside space-y-2 text-gray-700">
<li>This test contains 16 multiple choice questions.</li>
<li>Each question has only one correct answer.</li>
<li>You will have 26 minutes to complete the test.</li>
<li>Click or tap on an option to select your answer.</li>
<li>Use the "Mark for Review" button to revisit questions.</li>
<li>Navigate using Previous/Next buttons or the Questions Navigation panel.</li>
<li>Click "Submit" to finish and view results.</li>
<li>The test will auto-submit when time runs out.</li>
</ul>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="start-test">Start Test</button>


</div>
<div class="error-message hidden" id="error-message"></div>
</div>
</section>
<!-- Quiz Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="quiz">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<!-- Progress Bar -->
<div class="w-full bg-gray-200 rounded-full h-3 mb-4">
<div class="progress-bar h-3 rounded-full" id="progress-bar" style="width: 0%"></div>
</div>
<!-- Question Header -->
<div class="flex flex-col md:flex-row justify-between items-center mb-4">
<h2 class="text-lg font-semibold" id="question-number">Question <span>1</span> of 16</h2>
<p class="text-lg font-semibold mt-2 md:mt-0" id="timer">Time Remaining: <span>00:00</span></p>
</div>
<!-- Question Content -->
<div class="mb-6" id="question-content">
<p class="text-gray-800 mb-4" id="question-text"></p>
<div class="flex flex-wrap gap-4 mb-4" id="question-images"></div>
<div class="space-y-3" id="options"></div>
</div>
<!-- Navigation Buttons -->
<div class="flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition w-full md:w-auto" disabled="" id="previous-btn">Previous</button>
<button class="bg-yellow-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-yellow-400 transition w-full md:w-auto" id="mark-review">Mark for Review</button>
<button class="bg-blue-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="next-btn">Next</button>
<button class="bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full md:w-auto" id="nav-toggle">Questions Navigation</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="submit-test">Submit Test</button>
</div>
</div>
</section>
<!-- Results Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="results">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-2xl font-semibold mb-4">Asthma - Results</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-4 mb-6">
<p><strong>Correct:</strong> <span id="correct-count">0</span></p>
<p><strong>Wrong:</strong> <span id="wrong-count">0</span></p>
<p><strong>Unanswered:</strong> <span id="unanswered-count">0</span></p>
<p><strong>Marked for Review:</strong> <span id="marked-count">0</span></p>
</div>
<h3 class="text-lg font-semibold mb-4" id="result-question-number">Question <span>1</span> of 16</h3>
<div class="space-y-6" id="results-content"></div>
<div class="result-nav">
<button aria-label="Previous question result" class="result-nav-btn" disabled="" id="prev-result">Previous</button>
<button aria-label="Toggle results navigation panel" class="result-nav-btn" id="results-nav-toggle">Results Navigation</button>
<button aria-label="Next question result" class="result-nav-btn" id="next-result">Next</button>
</div>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="take-again">Take Again</button>
<button class="bg-gray-500 text-white px-6 py-2 rounded-lg hover:bg-gray-600 transition" id="review-test">Review Test</button>
</div>
</div>
</section>
<!-- Exit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="exit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Leave Test?</h2>
<p class="text-gray-700 mb-4">Your progress will be lost if you leave this page. Are you sure you want to exit?</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="continue-test">No, Continue</button>
<button class="bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition" id="exit-test">Yes, Exit</button>
</div>
</div>
</div>
<!-- Submit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="submit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Confirm Submission</h2>
<p class="text-gray-700 mb-2">You have attempted <span id="attempted-count">0</span> of 16 questions.</p>
<p class="text-gray-700 mb-4"><span id="unattempted-count">0</span> questions are unattempted.</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="cancel-submit">Cancel</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-green-600 transition" id="confirm-submit">Submit Test</button>
</div>
</div>
</div>
<!-- Quiz Navigation Panel -->
<div class="fixed inset-y-0 right-0 nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="nav-panel">
<h2 class="text-lg font-semibold mb-4">Questions Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-nav">Close</button>
</div>
<!-- Results Navigation Panel -->
<div class="fixed inset-y-0 right-0 results-nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="results-nav-panel">
<h2 class="text-lg font-semibold mb-4">Results Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="results-nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="results-nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-results-nav">Close</button>
</div>
<!-- JavaScript Logic -->
<script>
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog("Attempting to parse questions_json");
            questions = [{"text": "A 2-year-old child presents with the complaint of recurrent cough and breathing difficulty usually at night or early morning. On examination, the baby is slightly dyspneic with prolonged expiration and wheezes heard. Which of the following devices will be used most commonly by this child?", "options": [{"label": "A", "text": "A", "correct": false}, {"label": "B", "text": "B", "correct": false}, {"label": "C", "text": "C", "correct": true}, {"label": "D", "text": "D", "correct": false}], "correct_answer": "C. C", "question_images": ["https://dbmi-data.s3.ap-south-1.amazonaws.com/questionImage-1725359126115-photos-1725270863057-QTDK056001IMG1.JPG"], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>C The above case scenario is of an asthma patient. The age of the child is 2 years so the device most commonly used is MDI with a spacer with a facemask.</p>\n<p><strong>Highyeild:</strong></p><p>Metered Dose Inhaler (MDI) ROTAHALER Metered Dose Inhaler (MDI) with spacer with facemask Metered Dose Inhaler (MDI) with spacer Children <4-year-old: MDI with spacer with face mask Children >4-year-old: MDI with spacer preferred Children >12-year-old: MDI used directly. Use of spacer improves drug deposition.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 10-year-old girl presents with the complaint of recurrent cough, wheezing, and breathing difficulty usually at night or early morning. These symptoms are usually present daily. On examination, she is dyspneic, anxious, and has a prolonged expiration. Due to these symptoms, she is missing school which affects her studies. How will you manage the patient?", "options": [{"label": "A", "text": "Short-acting Î²-agonist (SABA) whenever symptoms", "correct": false}, {"label": "B", "text": "Low-dose inhaled steroids + SABA (Short-acting Î²-agonist)", "correct": false}, {"label": "C", "text": "Low-dose inhaled steroids + LABA (Long-acting Î²-agonist)", "correct": true}, {"label": "D", "text": "Low-dose inhaled steroids + Short-acting Î²-agonist (SABA) whenever required", "correct": false}], "correct_answer": "C. Low-dose inhaled steroids + LABA (Long-acting Î²-agonist)", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Low-dose inhaled steroids + LABA (Long-acting Î²-agonist) The above case scenario is of moderate persistent asthma patients. The child is anxious with increased respiratory rate, chest indrawing, and symptoms affecting her studies. So the management will include low dose Inhaled Corticosteroids ICS + LABALong -acting Î²-agonist or medium-dose ICS Inhaled Corticosteroids. STEPWISE TREATMENT OF ASTHMA: Symptoms Treatment Step 4: Severe persistent Continuous Limited physical activity High dose inhaled steroids+ Long-acting Î² 2 agonist Add montelukast Refer to special Step 3: Moderate persistent Daily use Î² 2 , agonist Daily attack affects activity Low dose inhaled steroids + Long-acting Î² 2 agonist OR Medium dose inhaled steroids Step 2: Mild persistent Low grade symptoms twice a month Nighttime awakening once per month Low dose inhaled steroids Short-acting Î² 2 , agonist, whenever symptoms Step 1: Intermittent Infrequent Asymptomatic and normal PEFR between attack Short-acting Î² 2 agonist, whenever symptoms</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 7-year-old child came with a recurrent cough and breathing difficulty usually at night or early morning. Her mother also had a history of asthma. Which of the following are diagnostic markers of asthma in children?", "options": [{"label": "A", "text": "Forced Expiratory Volume FEV1/ Forced Vital Capacity FVC less than 60%", "correct": false}, {"label": "B", "text": "Improve in Forced Expiratory Volume FEV1 > 12% after SABA Short-acting Î²-agonist", "correct": true}, {"label": "C", "text": "Diurnal Peak Expiratory Flow Rate PEFR variation more than or equal to 15%", "correct": false}, {"label": "D", "text": "Decrease in FEV1 by >20% during or after exercise", "correct": false}], "correct_answer": "B. Improve in Forced Expiratory Volume FEV1 > 12% after SABA Short-acting Î²-agonist", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Improve in Forced Expiratory Volume FEV1 > 12% after SABA Short-acting Î²-agonist Diagnostic markers of asthma in children are:- Forced Expiratory VolumeFEV1/Forced Vital Capacity FVC < 80% OR 0.8 Improvement in FEV1 >12% after Short-acting Î²-agonist SABA Diurnal Peak Expiratory Flow Rate PEFR variation >20% Decrease in FEV1 by 15% during or after exercises Exhaled nitric oxide >20ppb supports clinical diagnosis of asthma Low FEF 27 (a best marker of airway obstruction)</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "An 8-year-old child came with a history of asthma. Currently, his symptom has increased as he complains of recurrent cough, wheezing, and breathing difficulty early in the morning. His symptoms are coming daily despite daily use of Short-acting Î²-agonist SABA. In which category will you categorize the patient?", "options": [{"label": "A", "text": "Mild persistent", "correct": false}, {"label": "B", "text": "Moderate persistent", "correct": true}, {"label": "C", "text": "Severe persistent", "correct": false}, {"label": "D", "text": "Intermittent persistent", "correct": false}], "correct_answer": "B. Moderate persistent", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Moderate persistent The above case scenario is of moderate persistent asthma. STEPWISE TREATMENT OF ASTHMA: Symptoms Treatment Step 4: Severe persistent Continuous Limited physical activity High dose inhaled steroids+ Long-acting Î² 2 agonist Add montelukast Refer to special Step 3: Moderate persistent Daily use Î² 2 , agonist Daily attack affects activity Low dose inhaled steroids + Long-acting Î² 2 agonist OR Medium dose inhaled steroids Step 2: Mild persistent Low grade symptoms twice a month Nighttime awakening once per month Low dose inhaled steroids Short-acting Î² 2 , agonist, whenever symptoms Step 1: Intermittent Infrequent Asymptomatic and normal PEFR between attack Short-acting Î² 2 agonist, whenever symptoms GRADING OF SEVERITY OF ASTHMA Clinical parameter Mild Moderate Bovoro Color Normal Normal Pale Sensorium Normal Anxious Agitated Respiratory rate Increased Increased Increased Dyspnea Absent Moderate Severe Speech Can speak sentancos Can speak in phrases Difficulty in speech Use of accessory muscles Nil or minimal Chost Indrawing Indrawing; nasal flare Pulsus paradoxus 10 mm 10-20 mm >20 mm Rhonchi Expiratory and/or Inspiratory Expiratory and/or Inspiratory Expiratory or absent Peak expiratory flow rate >80% 60-80% <80% Oxygen saturation >95% 00-05% <90%</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "In the above patient, what will be the recommended management?", "options": [{"label": "A", "text": "Short-acting Î²-agonist (SABA) + low dose ICS Inhaled Corticosteroids", "correct": false}, {"label": "B", "text": "Short-acting Î²-agonist SABA + medium dose ICS Inhaled Corticosteroids", "correct": true}, {"label": "C", "text": "Short-acting Î²-agonist SABA+ high dose ICS Inhaled Corticosteroids", "correct": false}, {"label": "D", "text": "Short-acting Î²-agonist (SABA) + high dose Inhaled Corticosteroids (ICS) Long-acting Î²-agonist (LABA)", "correct": false}], "correct_answer": "B. Short-acting Î²-agonist SABA + medium dose ICS Inhaled Corticosteroids", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Short-acting Î²-agonist SABA + medium dose ICS Inhaled Corticosteroids The above case scenario is of moderate persistent asthma. The management will include- Short-acting Î²-agonist SABA + medium dose ICS Inhaled Corticosteroids or low dose ICS Inhaled Corticosteroids + LABA Long-acting Î²-agonist. STEPWISE TREATMENT OF ASTHMA:- Symptoms Treatment Step 4: Severe persistent Continuous Limited physical activity High dose inhaled steroids+ Long-acting Î² 2 agonist Add montelukast Refer to special Step 3: Moderate persistent Daily use Î² 2 , agonist Daily attack affects activity Low dose inhaled steroids + Long-acting Î² 2 agonist OR Medium dose inhaled steroids Step 2: Mild persistent Low grade symptoms twice a month Nighttime awakening once per month Low dose inhaled steroids Short-acting Î² 2 , agonist, whenever symptoms Step 1: Intermittent Infrequent Asymptomatic and normal PEFR between attack Short-acting Î² 2 agonist, whenever symptoms</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 9-year-old came with complaining of recurrent cough, wheezing, and breathing difficulty usually twice a month though he is able to do his daily activities normally. His mother also had a history of asthma. What will be the recommended management of this patient?", "options": [{"label": "A", "text": "Short-acting Î²-agonist SABA as needed", "correct": false}, {"label": "B", "text": "Short-acting Î²-agonist SABA as needed + low dose ICS-Inhaled Corticosteroids", "correct": true}, {"label": "C", "text": "Short-acting Î²-agonist SABA daily + low dose ICS- Inhaled Corticosteroids", "correct": false}, {"label": "D", "text": "Short-acting Î²-agonist SABA as needed + medium dose ICS-Inhaled Corticosteroids", "correct": false}], "correct_answer": "B. Short-acting Î²-agonist SABA as needed + low dose ICS-Inhaled Corticosteroids", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Short-acting Î²-agonist SABA as needed + low dose ICS-Inhaled Corticosteroids The above case scenario is of mild persistent asthma. The management will include SABA as needed + low dose ICS. STEPWISE TREATMENT OF ASTHMA: Symptoms Treatment Step 4: Severe persistent Continuous Limited physical activity High dose inhaled steroids+ Long-acting Î² 2 agonist Add montelukast Refer to special Step 3: Moderate persistent Daily use Î² 2 , agonist Daily attack affects activity Low dose inhaled steroids + Long-acting Î² 2 agonist OR Medium dose inhaled steroids Step 2: Mild persistent Low grade symptoms twice a month Nighttime awakening once per month Low dose inhaled steroids Short-acting Î² 2 , agonist, whenever symptoms Step 1: Intermittent Infrequent Asymptomatic and normal PEFR between attack Short-acting Î² 2 agonist, whenever symptoms</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "The above patientâ€™s symptoms will be categorized as?", "options": [{"label": "A", "text": "Intermittent symptoms", "correct": false}, {"label": "B", "text": "Mild persistent symptoms", "correct": true}, {"label": "C", "text": "Moderate persistent symptoms", "correct": false}, {"label": "D", "text": "Severe persistent symptoms", "correct": false}], "correct_answer": "B. Mild persistent symptoms", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Mild persistent symptoms The above case scenario is of mild persistent asthma. STEPWISE TREATMENT OF ASTHMA: Symptoms Treatment Step 4: Severe persistent Continuous Limited physical activity High dose inhaled steroids+ Long-acting Î² 2 agonist Add montelukast Refer to special Step 3: Moderate persistent Daily use Î² 2 , agonist Daily attack affects activity Low dose inhaled steroids + Long-acting Î² 2 agonist OR Medium dose inhaled steroids Step 2: Mild persistent Low grade symptoms twice a month Nighttime awakening once per month Low dose inhaled steroids Short-acting Î² 2 , agonist, whenever symptoms Step 1: Intermittent Infrequent Asymptomatic and normal PEFR between attack Short-acting Î² 2 agonist, whenever symptoms GRADING OF SEVERITY OF ASTHMA Clinical parameter Mild Moderate Bovoro Color Normal Normal Pale Sensorium Normal Anxious Agitated Respiratory rate Increased Increased Increased Dyspnea Absent Moderate Severe Speech Can speak sentancos Can speak in phrases Difficulty in speech Use of accessory muscles Nil or minimal Chost Indrawing Indrawing; nasal flare Pulsus paradoxus 10 mm 10-20 mm >20 mm Rhonchi Expiratory and/or Inspiratory Expiratory and/or Inspiratory Expiratory or absent Peak expiratory flow rate >80% 60-80% <80% Oxygen saturation >95% 00-05% <90%</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following conditions will be considered in a life-threatening asthma? Cyanosis Silent chest (Peak Expiratory Flow Rate) PEFR < 20% of predicted Altered sensorium Oxygen saturation < 85% Select the correct answer from given below code:-", "options": [{"label": "A", "text": "1, 2, and 4", "correct": false}, {"label": "B", "text": "1, 2, 3, and 4", "correct": false}, {"label": "C", "text": "1, 2, and 5", "correct": false}, {"label": "D", "text": "1, 2, 3, 4, and 5", "correct": true}], "correct_answer": "D. 1, 2, 3, 4, and 5", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>1, 2, 3, 4, and 5 When to consider life-threatening asthma: Cyanosis Silent chest Peak Expiratory Flow Rate (PEFR) <30% of predicted Altered sensorium Oxygen saturation <90%</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 14-year-old child came with the complaint of recurrent cough, wheezing, and breathing difficulty usually early in the morning. These symptoms occur almost daily despite using high doses (Inhaled Corticosteroid) of ICS. His mother also had a history of asthma. Which IgE antibody is used nowadays?", "options": [{"label": "A", "text": "OMALIZUMAB", "correct": true}, {"label": "B", "text": "MEPOLIZUMAB", "correct": false}, {"label": "C", "text": "DUPILUMAB", "correct": false}, {"label": "D", "text": "ADALIMUMAB", "correct": false}], "correct_answer": "A. OMALIZUMAB", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>OMALIZUMAB The IgE antibody used for asthma nowadays is It binds to IgE and blocks its action on the IgE receptor. Indicated in children > 6 years with severe asthma on the max dose of ICS/OCS</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 15-year-old child came with the complaint of recurrent cough, wheezing, and breathing difficulty usually early in the morning. These symptoms occur almost daily despite using high doses of Inhaled Corticosteroids ICS. His mother also had a history of asthma. Doctor advised him to give MEPOLIZUMAB. What is the mechanism of action of this drug?", "options": [{"label": "A", "text": "Anti-IgE antibody", "correct": false}, {"label": "B", "text": "Anti-IL-5 antibody", "correct": true}, {"label": "C", "text": "Anti-IL-4 antibody", "correct": false}, {"label": "D", "text": "Anti-IL-13 antibody", "correct": false}], "correct_answer": "B. Anti-IL-5 antibody", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Anti-IL-5 antibody MEPOLIZUMAB is an anti IL-5 . It blocks IL-5-mediated eosinophilopoiesis. Indicated in children > 12 years with severe eosinophilic asthma.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following is not included in the discharge criteria of the patient with asthma from the hospital?", "options": [{"label": "A", "text": "Patient should be on discharge medications for 12 hrs prior to discharge.", "correct": true}, {"label": "B", "text": "Correct inhaler technique is checked and recorded", "correct": false}, {"label": "C", "text": "If the recorded Peak Expiratory Flow Rate PEFR is >75% of predicted of the best and Peak Expiratory Flow Rate PEFR diurnal variation is < 20%, treatment should include soluble steroids and inhaled steroids in addition to the bronchodilation", "correct": false}, {"label": "D", "text": "Patients should be given a self-management plan or instructions should be given to the parents", "correct": false}], "correct_answer": "A. Patient should be on discharge medications for 12 hrs prior to discharge.", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Patient should be on discharge medications for 12 hrs prior to discharge. Discharge criteria from the hospital include: Patients should be on discharge medication for 24 hours prior to discharge. The correct inhaler technique is checked and recorded. If recorded PEFR >75% of predicted the best and PEFR diurnal variation is less than 20%, treatment should include soluble steroids tablets and inhaled steroids in addition to the bronchodilator. The patient should be given a self-management plan or instructions should be given to the parents.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 15-year-old child came to a paediatric emergency with the complaint of recurrent cough, wheezing, and breathing difficulty since morning. His symptoms are continuous for the past 1 week despite the use of SABA + high dose ICS + LABA. Currently, he is unconscious. What will be the management of this patient?", "options": [{"label": "A", "text": "Injection terbutaline s/c", "correct": false}, {"label": "B", "text": "Inhaled salbutamol", "correct": false}, {"label": "C", "text": "Injection hydrocortisone", "correct": false}, {"label": "D", "text": "All of the above", "correct": true}], "correct_answer": "D. All of the above", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>All of the above The above case scenario is of life-threatening asthma. The presence of any of the following indicates life-threatening asthma. Cyanosis, silent chest, poor respiratory efforts, exhaustion or fatigue, altered sensorium, PEFR<30% of predicted, and oxygen saturation <90%. Such patients should immediately receive oxygen by mask or hood. An injection of terbutaline or adrenaline is given subcutaneously, inhalation of salbutamol or terbutaline and ipratropium is started, an injection of hydrocortisone (5 mg/kg) is given and arrangements are made to transfer the patient to an intensive care unit (ICU) preferably with an accompanying physician. If the patient shows improvement, the salbutamol/ terbutaline inhalation is continued every 20-30 minutes, and hydrocortisone (3-5 mg/kg) is continued every 6-8 hours till the patient starts accepting orally. If the patient does not improve or deteriorate a slow IV infusion of magnesium sulfate (SO mg/kg) or a loading dose of theophylline is given. If there is no improvement with this management, the patient is prepared for mechanical ventilation. Patients should also be screened for causes of poor response such as acidosis, pneumothorax, electrolyte imbalance and infection, and treated accordingly.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "An infant presented with erythematous lesions on the cheek, and extensor aspect of limbs, mother has a history of bronchial asthma, and the probable diagnosis is:", "options": [{"label": "A", "text": "Airborne contact dermatitis", "correct": false}, {"label": "B", "text": "Atopic dermatitis", "correct": true}, {"label": "C", "text": "Seborrheic dermatitis", "correct": false}, {"label": "D", "text": "Infectious eczematoid dermatitis", "correct": false}], "correct_answer": "B. Atopic dermatitis", "question_images": ["https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1682884939517-QTDK056013IMG1.JPG"], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Atopic dermatitis Atopic dermatitis is associated with a history of bronchial asthma.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 7-year-old child, known for severe persistent asthma, on Inhaled Corticosteroids ICS and salmeterol combination + montelukast arrives in an emergency in severe respiratory distress, cyanosis, and chest auscultation reveals silent chest. The child is not able to speak sentences. What is the first step of management in this child?", "options": [{"label": "A", "text": "Salbutamol by nebulisation", "correct": false}, {"label": "B", "text": "Subcutaneous adrenaline", "correct": false}, {"label": "C", "text": "Intubation", "correct": false}, {"label": "D", "text": "Oxygen by mask", "correct": true}], "correct_answer": "D. Oxygen by mask", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Oxygen by mask The first line of management of severe persistent asthma is oxygen by mask.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following is most commonly preferred in the 5-year-old asthma patient?", "options": [{"label": "A", "text": "A", "correct": false}, {"label": "B", "text": "B", "correct": true}, {"label": "C", "text": "C", "correct": false}, {"label": "D", "text": "D", "correct": false}], "correct_answer": "B. B", "question_images": ["https://dbmi-data.s3.ap-south-1.amazonaws.com/questionImage-1725359186495-photos-1725270863418-QTDK056015IMG1.JPG"], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>B Children < 4-year-old: MDI Metered Dose Inhaler with spacer with face mask Children >4-year-old: MDI Metered Dose Inhaler with spacer preferred Children >12-year-old: MDI Metered Dose Inhaler used directly. The use of a spacer improves drug deposition. MDI Metered Dose Inhaler with spacer with facemask MDI Metered Dose Inhaler with spacer ROTAHALER MDI Metered Dose Inhaler</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following is an indication of using mast cell stabilizers in childhood asthma?", "options": [{"label": "A", "text": "Aspirin-induced asthma", "correct": false}, {"label": "B", "text": "Severe asthma", "correct": false}, {"label": "C", "text": "Exercise-induced asthma", "correct": true}, {"label": "D", "text": "Status asthmaticus", "correct": false}], "correct_answer": "C. Exercise-induced asthma", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Exercise-induced asthma Mast cell stabilizers (such as cromolyn sodium and nedocromil sodium) inhibit the degranulation of mast cells and be effective for preventing exercise-induced bronchospasm and as a treatment option in mild-moderate asthma.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error("Questions data is empty or invalid");
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error("Failed to parse questions_json:", e);
            document.getElementById(